The price of furmonertinib is influenced by factors such as drug specifications, regional differences and medical insurance policies, with the price per box ranging approximately from500 to 800 USD. The specific cost is subject to the pricing of hospitals or pharmacies in the patient's locality and whether the drug is covered by medical insurance reimbursement. This medication is primarily indicated for the treatment of specific types of non-small cell lung cancer (NSCLC) and must be used under the guidance of a physician.
Price-influencing Factors
Drug specifications: Price variations may occur due to different dosages (e.g., 40mg/tablet, 80mg/tablet) or the number of tablets per box (30 tablets/box in most cases).
Regional policies: Some provinces and cities may further lower patients' out-of-pocket proportion through local medical insurance or supplementary insurance schemes.
Medical insurance reimbursement: If patients meet the indications specified in the national medical insurance catalog (e.g., advanced NSCLC with positive EGFR T790M mutation), their out-of-pocket expenses may be significantly reduced after medical insurance reimbursement.
Suggestions on Cost Inquiry and Purchase
Hospitals or licensed pharmacies
It is recommended to purchase the medication through medical institutions or qualified platforms to avoid products from unconfirmed sources.
Medical insurance consultation
Contact the local medical insurance department or the medical insurance office of the hospital to learn about the reimbursement criteria and procedures.
Precautions
Strictly follow the physician’s instructions
Furmonertinib shall be used based on genetic testing results, and patients are not allowed to adjust the dosage or discontinue the medication on their own.
Side effect monitoring
Common side effects include diarrhea and skin rashes; prompt medical attention is required if severe symptoms occur.
Regular reexaminations
During the treatment period, imaging examinations and blood tests are needed to evaluate the therapeutic effect and drug resistance status.
Medical Guidance
For patients who need to take this medication, it is recommended to visit specialized oncology hospitals or departments such as respiratory medicine and thoracic surgery, where physicians will formulate individualized treatment plans. Patients with financial difficulties may pay attention to charitable drug donation programs or participate in clinical trials if they meet the eligibility criteria.
Note: The price of the medication may change with policy adjustments, and the actual cost at the time of purchase shall prevail.
